ArticleJournal of rheumatic diseases2025

Understanding and addressing anti-drug antibody formation in tumor necrosis factor-α inhibitor therapy for ankylosing spondylitis.

Tae-Jong KimPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.